| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
De Rubertis Francesco is a Director, 10% Owner at Minerva Neurosciences, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 13 buys and 1 sell.
Estimated insider holdings value: $38.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | CNTA Centessa Pharmaceuticals Plc | Director | Buy | 34,326 | $12.82 | $440,059.32 | +0.9% | -31.0% | -69.7% | |
| Dec 1, 2021 | CNTA Centessa Pharmaceuticals Plc | Director | Buy | 97,151 | $12.24 | $1,189,198.62 | +1.2% | -29.1% | -67.6% | |
| Nov 29, 2021 | CNTA Centessa Pharmaceuticals Plc | Director | Buy | 68,523 | $11.64 | $797,426.45 | +0.9% | -22.8% | -66.3% | |
| Jun 2, 2021 | CNTA Centessa Pharmaceuticals Plc | Director | Buy | 600,000 | $20.00 | $12,000,000.00 | +18.6% | -12.2% | -87.1% | |
| Aug 10, 2016 | NERV Minerva Neurosciences, Inc. | Director, 10% Owner | Sell | 1,000,000 | $10.00 | $10,000,000.00 | -18.2% | - | - | |
| Mar 18, 2015 | NERV Minerva Neurosciences, Inc. | Director, 10% Owner | Buy | 202,634 | $4.81 | $974,669.54 | +3.8% | - | - |